Cardiovascular System Modeling and Control [F-18-10]
|Location:||SUNY: Maxcy 104|
|Classes:||1 Session 1.5 hours|
|Dates:||Mon 10:30 AM 11/05|
About 5.7 million adults in the U.S. have heart failure (HF), and the annual cost of health care services to treat HF is approximately $30.7 billion. The therapeutic option for end-stage HF is heart transplantation. However, only approximately 10% of these patients can receive transplantations due to limited donor hearts. Left Ventricular Assist Device (LVAD) implantation becomes an important treatment option; however, proving that LVAD can work safely and effectively before the implantation can be a challenge. High-quality engineering models offer a potential solution for addressing this challenge. Learn about a new generation of cardiovascular biomechanics models and how such models can be used for the control of LVAD, while considering different physiological activities of HF patients such as sleeping and exercise.
Yuncheng Du finished his PhD in Chemical Engineering at the University of Waterloo, Ontario, Canada in 2016. His research focuses on control theory and its application in chemical processes, biological processes, and biomedical engineering. Currently, he is working on personalized modeling and therapy planning for heart failure patients, and optimization of biopharmaceutical processes.